Table 2.
Estimate (95% CI) | P | |
---|---|---|
Long-term survivor model (OR) | ||
TT1 (ref.) | ||
TT2− | 4.75 (2.22–10.18) | 0.036 |
TT2+ | 2.36 (1.06–5.26) | <0.001 |
TT3 | 20.23 (9.11–44.90) | <0.001 |
Age | 0.97 (0.95–0.97) | 0.018 |
Cytogenetic abnormalities | 0.42 (0.25–0.70) | 0.001 |
Short-term survival model (HR) | ||
TT1 (ref.) | ||
TT2− | 0.77 (0.59–1.00) | 0.052 |
TT2+ | 0.66 (0.48–0.93) | 0.017 |
TT3 | 0.92 (0.52–1.64) | 0.78 |
Age | 1.00 (0.999–1.02) | 0.25 |
Cytogenetic abnormalities | 1.41 (1.15–1.73) | 0.001 |